MRSN
USDMersana Therapeutics Inc. Common Stock
Echtzeitkurs
Kursdiagramm
Schlüsselkennzahlen
Marktkennzahlen
Eröffnung
$9.065
Hoch
$9.065
Tief
$8.000
Volumen
0.03M
Unternehmensfundamentaldaten
Marktkapitalisierung
40.7M
Branche
Biotechnologie
Land
United States
Handelsstatistiken
Durchschnittliches Volumen
0.07M
Börse
NMS
Währung
USD
52-Wochen-Spanne
Ähnliche Nachrichten
Truist Securities Maintains Buy on Mersana Therapeutics, Adjusts Price Target To $36 from $250
Truist Securities analyst Asthika Goonewardene maintains Mersana Therapeutics with a Buy, Adjusts Target to $36 from $250
Guggenheim Maintains Buy on Mersana Therapeutics, Lowers Price Target to $30
Guggenheim analyst Michael Schmidt maintains Mersana Therapeutics with a Buy and lowers the price target from $125 to $30.
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics, Inc. (MRSN) Q2 2025 Earnings Call Transcript
Mersana Therapeutics Provides Business Update and Announces Second Quarter 2025 Financial Results
More than 45 patients enrolled in Emi-Le Phase 1 dose expansion cohorts in post-topoisomerase-1 inhibitor ADC (post-topo-1) triple-negative breast cancer (TNBC)Plan to report initial clinical data from Emi-Le expansion
Mersana Therapeutics to Host Second Quarter 2025 Conference Call on August 13, 2025
CAMBRIDGE, Mass., Aug. 06, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on the development of antibody-drug conjugates (ADCs) targeting cancers
Ähnliche Aktien
Bleiben Sie auf dem Laufenden
Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.